why choose us

First received: June 14, 2023

Clinical Trial: A Study to Compare Two Formulations of LY3209590 in Healthy Participants

Study Status: Completed

Recruit Status: RECRUITING

Condition: Healthy

Study Type: INTERVENTIONAL


Official Title: A Bioequivalence Study of Subcutaneous Injections of LY3209590 in Two Formulations in Healthy Participants

Brief Summary: The main purpose of this study is to compare the two formulations of LY3209590 in healthy participants.Study participants will be administered each formulation at separate study visits.Blood samples will be taken to compare how the body handles study drugs.The information about any adverse effects experienced will be collected and the tolerability of LY3209590 will also be evaluated.Screening is required within 28 days prior to enrolment.For each participant, the total duration of the clinical trial will be about…

Read more